JPM Brand Name

Torvacol Generic Name

Atorvastatin calcium

Lipid Lowering Drugs
Indications As an adjunct to diet to reduce elevated total-C, LDL-C, apo B, and TG levels and to increase HDL-C in patients with primary hypercholesterolemia (Heterozygous Familial and Nonfamilial) and mixed dyslipidemia (Fredrickson Types IIa and IIb).

As an adjunct to diet in treatment of patients with elevated serum triglyceride levels (Fredrickson Type IV).
For the treatment of patients with primary dysbetalipoproteinemia (Fredrickson Type III) who do not respond adequately to diet.
To reduce total-C and LDL-C in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid lowering treatments (e.g., LDL apheresis) or if such treatments are unavailable.

As an adjunct to diet to reduce total-C, LDL-C, and apo B levels in boys and postmenarchal girls, 10 to 17 years of age, with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present:
LDL-C remains ≥ 190mg/dL; or,LDL-C remains ≥ 160 mg/dL and there is a positive family history of premature cardiovascular disease (CVD) or two or more other CVD risk factors are present in the pediatric patient.